Leonhard Lang Gmbh Archenweg 56 Innsbruck Austria S&W Electrodes for Defibrillation, 10 Defibrillation Electrodes, Reorder #90101, S & W Healthcare Corp, 1525 Flight Path Drive Brooksville, Florida 34604 The device is non-sterile and single use. For use on adults and children over eight years old for external defibrillation, pacing, monitoring, and cardioversion. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
S&W Electrodes for Defibrillation, 10 Defibrillation Electrodes, Reorder #90101, S & W Healthcare Corp, 1525 Flight Path Drive Brooksville, Florida 34604 The device is non-sterile and single use. For use on adults and children over eight years old for external defibrillation, pacing, monitoring, and cardioversion.
Brand
Leonhard Lang Gmbh Archenweg 56 Innsbruck Austria
Lot Codes / Batch Numbers
DF-20 S&W Lot #'s 80505-0778, 80814-0773, 80930-0775, 81017-0777, 90226-0776, 90403-0779, 90420-0775
Products Sold
DF-20 S&W Lot #'s 80505-0778, 80814-0773, 80930-0775, 81017-0777, 90226-0776, 90403-0779, 90420-0775
Leonhard Lang Gmbh Archenweg 56 Innsbruck Austria is recalling S&W Electrodes for Defibrillation, 10 Defibrillation Electrodes, Reorder #90101, S & W Healthcare Co due to A potential risk was identified associated with the connectors of the defibrillation electrodes DF20. It was found that some of the connectors do not . Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
A potential risk was identified associated with the connectors of the defibrillation electrodes DF20. It was found that some of the connectors do not slip easily into the sockets of the defibrillator or an extension cord of the defibrillator. In such cases increased force or some wiggling is required to insert the connector fully. A potential risk for patients exist, if (a) such a connector (b)
Recommended Action
Per FDA guidance
A Leonhard Lang letter dated June 9, 2009 was sent June 6, 2009 to its customer. The letter identified the problem and the product. The letter instructed the consignee to stop using or distributing the product and to quarantine them. It also requested them to report all quantities of product that they had in stock using the attached form.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
FL
Page updated: Jan 10, 2026